PlexusDx does not sell, prescribe, or recommend it, and this article provides no dosing or sourcing guidance
What Does the Research Actually Show About Candidate Selection
Some GLP-1 drugs like Wegovy and Saxenda are FDA-approved specifically for weight loss, independent of diabetes
Key Facts About Retatrutide 30mg Compound: Retatrutide Research identifier: LY3437943 Research class: Triple receptor agonist model Pathways studied: GLP-1, GIP, and glucagon receptor pathways Common search terms: GLP-3, GLP-R, triple agonist peptide, next-generation GLP-1 research compound Format: Lyophilized research peptide Use: Laboratory research only Retatrutide 30mg Research Compound Overview Retatrutide 30mg is a high-purity, batch-verified research peptide supplied for laboratories requiring consistency, analytical precision, traceability, and controlled sourcing
Sensitivity analyses were further conducted for each subtype of intestinal obstruction